• A Critical Appraisal of Tools for Improving Success or Safety of Atrial Fibrillation Ablation (CA-537)
• Acute and Long-Term Outcomes after Pulsed Field Ablation for the Treatment of Atrial Fibrillation (CA-536)
• Adjunctive Methods for Improving Safety and Efficacy of Catheter Ablation (CA-491)
• Advances in Clinical Trials (CA-746)
• Best Approaches for Ablation of Long-Standing Persistent Atrial Fibrillation (CA-377)
• Best Strategies for Safe Access to the Epicardial Space (CA-359)
• Building a Better Lesion: Investigations into Radiofrequency and Pulsed Field Ablation Biophysics (CA-527)
• Cardiac Pulsed Field Ablation - Unfolding the Mysteries (JS-448)
• Cardioneuroablation: Patient Selection, Mapping, and Ablation (CA-069)
• Case Based Approaches for Targeting Intramural Ventricular Substrate (CA-489)
• Case Based Approaches to Difficult Supraventricular Tachycardia Ablations (CA-355)
• Challenging Ablation Cases and Unusual Approaches (CA-141)
• Complex Cases for the Ablationist (PC-577)
• Debate: Ablation of Atrial Fibrillation is a Life-Saving Procedure (CA-362)
• Debate: Less is More when Ablating Persistent Atrial Fibrillation (CA-363)
• Defining Endpoints for Ventricular Tachycardia Ablation: A Case-Based Approach (CA-239)
• Delivering Durable Lesions: Utilizing Surrogates to Guide Ablation in the Atrium and Ventricle (CA-530)
• Effects of Pulse Field Ablation on Ventricular Myocardium and Coronary Arteries (CA-534)
• Experimental and Clinical Research into Esophageal Protection from Ablation Related Injury (CA-528)
• Expert Guidance for Ablation of Persistent Atrial Fibrillation (CA-365)
• Expert Tutorial: Advanced Ablation Techniques - Tips and Tricks (CA-385)
• High-Power Short Duration Radiofrequency Ablation for Pulmonary Vein Isolation: Clinical Trials (CA-535)
• Insights and Innovations in Ventricular Arrhythmia Ablation (CA-531)
• Interventions for Atrial Fibrillation in Patients with Heart Failure: Lessons Learned from Recent Randomized Trials (CA-147)
• Investigations into Stereotactic Body Radiation Therapy for Ventricular Tachycardia (CA-533)
• Late-Breaking Clinical Trials: Randomized Clinical Trials (LB-733)
• Mapping Techniques to Elucidate Mechanisms and Aid Ablation Strategy in Atrial Fibrillation Ablation (CA-529)
• Mechanisms of Esophageal Injury and Strategies for Esophageal Protection During Ablation of Atrial Fibrillation (CA-037)
• New Techniques and Tools for Overcoming the Challenges of VT Ablation (JS-455)
• Nightmare Ablation Cases (CA-360) Novel Treatment Strategy for Ventricular Arrhythmias (JS-454)
• Optimal Ablation Parameter Settings to Achieve the Best Lesions (CA-490)
• Practical Anatomy for Ablation: Lessons from the McAlpine Atlas (CA-313)
• Pulsed Field Ablation: Expectations and Updated Clinical Data (CA-386)
• Recorded Cases: Ablation (RC-730)
• Targeting the Vein of Marshall for Ablation of Atrial Fibrillation: Hope or Hype? (CA-488)
• Tense Moments and Great Saves in Catheter Ablation (CA-344)
• Treatment Strategies for Atrial Fibrillation and Associated Outcomes (CA-532)
• When Standard Radiofrequency Ablation Fails: Innovations in Ablation for Refractory Ventricular Arrhythmias (CA-138)

After watching a reasonable amount of Catheter Ablation (Heart Rhythm 2022), the learner should be able to:

• Identify and analyze the latest scientific advances and innovations in the field of heart rhythm disorders.
• Select appropriate, evidence-directed pharmacological and non-pharmacological therapies to achieve optimal outcomes for patients with heart rhythm disorders.
• Recognize alternative perspectives regarding areas of controversy for which scientific evidence is insufficient, controversial, inconclusive, or confusing.
• Utilize quality improvement measures, methods, and tools to foster systems-based improvements in heart rhythm care, outcome, and value.
• Analyze and improve processes related to inter-professional teams, care coordination, patient engagement, and communication to optimize the delivery of patient- and family-centered care.
• Assess the impact of regulatory and institutional policies, and societal and cultural norms, on safety, timeliness, equity (including diversity and inclusion), effectiveness, efficiency, patient-centered care, and value.
• Utilize improved communication methods to engage with patients and caregivers for increased shared decision-making in the treatment of heart rhythm disorders
• Evaluate the latest technology available for both professionals and consumers in the field of heart rhythm disorders.
• Recognize disparities in health care and describe strategies to reduce these disparities in patient care.
• Utilize shared decision-making resources in discussing monitoring and treatment of patients with heart rhythm disorders.
• Describe the latest cardiac device advisories and/or recalls and explain how to share this information with patients and caregivers.
• Explain the current and future trends in digital health that will impact the treatment of heart rhythm disorders.
• Describe best practices for managing a device clinic, an AF center, and/or a multidisciplinary electrophysiology practice.

Learning objectives specific to the session are listed at the individual session within Catheter Ablation (Heart Rhythm 2022).

Accreditation Statement
The Heart Rhythm Society is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Physicians AMA Designation Statement
The Heart Rhythm Society designates this internet enduring activity for a maximum of 26 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ABIM Maintenance of Certification (MOC) Statement 

Royal College of Physicians and Surgeons of Canada MOC Recognition Statement
Through an agreement between the Accreditation Council for Continuing Medical Education and the Royal College of Physicians and Surgeons of Canada, medical practitioners participating in the Royal College MOC Program may record completion of accredited activities registered under the ACCME’s “CME in Support of MOC” program in Section 3 of the Royal College’s MOC Program.

Other Credit Available
A Credit Certificate (for physicians) or Certificate of Participation (for non-physicians) will be provided to individuals seeking credit from the following organizations which accept AMA PRA Category 1 Credit(s)™. Note that participants are advised to contact their certifying body for specific information regarding credit submissions:
·         American Academy of Family Physicians (AAFP) (for elective credit)
·         American Academy of Nurse Practitioners Certification Board (AANPCB)
·         American Academy of Physician Assistants (AAPA)
·         American Nurses Credentialing Center (ANCC)
·         American Osteopathic Association (AOA) (for Category 2 credit)
·         Committee on Accreditation of Continuing Medical Education (Canada)
·         European Board for Accreditation in Cardiology (EBAC)
·         European CME Credits (ECMEC)
·         German Chambers of Physicians
·         National Society of Genetic Counselors (for Category 2 credit)
·         Oman Medical Specialty Board
·         Qatar Council for Healthcare Practitioners
·         Royal College of Physicians and Surgeons of Canada (RCPSC)

Disclosure Policy

The Heart Rhythm Society is committed to the provision of Accredited Continuing Education (formerly known as Continuing Medical Education (CME)) that is balanced, objective, and evidence based. HRS adheres to the Standards for Integrity and Independence in Accredited Continuing Education of the Accreditation Council for Continuing Medical Education (ACCME) which require that those individuals in a position to control the content of an educational activity (including, but not limited to, planners, faculty, authors, committee members, content reviewers, editors, and staff) disclose all financial relationships with an ACCME-defined ineligible company* within the 24 months prior to the disclosure.

Any individual who refuses to disclose financial relationships is disqualified from participating in HRS ACE-certified activities. Owners and employees of ACCME-defined ineligible companies may have no role in the planning or implementation of ACE activities without a special written exemption from the HRS Chief Learning Officer that will be granted only in specific circumstances that meet ACCME requirements.

ACCME Definition:

*An ineligible company is one whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

Examples of such organizations include:

• Advertising, marketing, or communication firms whose clients are ineligible companies
• Bio-medical startups that have begun a governmental regulatory approval process
• Compounding pharmacies that manufacture proprietary compounds
• Device manufacturers or distributors
• Diagnostic labs that sell proprietary products
• Growers, distributors, manufacturers or sellers of medical foods and dietary supplements
• Manufacturers of health-related wearable products
• Pharmaceutical companies or distributors
• Pharmacy benefit managers
• Reagent manufacturers or sellers

The Heart Rhythm Society is committed to the provision of Accredited Continuing Education (formerly known as Continuing Medical Education (CME)) that is balanced, objective, and evidence based. HRS adheres to the Standards for Integrity and Independence in Accredited Continuing Education of the Accreditation Council for Continuing Medical Education (ACCME) which require that those individuals in a position to control the content of an educational activity (including, but not limited to, planners, faculty, authors, committee members, content reviewers, editors, and staff) disclose all financial relationships with an ACCME-defined ineligible company within the 24 months prior to the disclosure.

The Heart Rhythm Society takes steps to assure its learners and the public that the content of certified activities is accurate and reliable. The following principles are applied to the process of validating CME content. The content is peer-reviewed to ensure the following:

Fair Balance - that content is balanced among various options available for treatment and not biased toward a particular product or manufacturer.

Patient Treatment Recommendations - that patient treatment recommendations contained in the content are evidence-based, are appropriate for the target audience, and that the patient treatment recommendations contribute to overall improvement in patient care.

Scientific Validity - those scientific studies cited in the activity conform to standards accepted by the scientific community.

Learning Objectives - that the educational content supports the learning objectives of the activity, and that the objectives stated for performance-in-practice are actionable and measurable.
Omissions - that no seminal studies, data, or best evidence are missing.

ACE (formerly CME) and CoP Certificates will be awarded and available to download and print following the completion of the course and the course evaluation. Should you have any questions regarding your certificate(s), please contact CME@HRSonline.org.